CONSULTING AGREEMENTConsulting Agreement • December 4th, 2023 • Theseus Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledDecember 4th, 2023 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (the “Agreement”), dated as of December 7, 2023 (the “Effective Date”), is between Theseus Pharmaceuticals, Inc., a Delaware corporation with a place of business at 314 Main Street, Suite 04-200, Cambridge, MA 02142, USA (“Company”) and David Kerstein, an individual having an address at 1 James Millen Rd., North Reading, MA 01864-2985 (“Consultant”). Consultant and Company (each a “Party”; collectively, the “Parties”) agree as follows:
December 7, 2023 Via Electronic Mail Tim ClacksonSeparation and Release Agreement • December 4th, 2023 • Theseus Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledDecember 4th, 2023 Company Industry JurisdictionAs discussed, your employment with Theseus Pharmaceuticals, Inc. (the “Company”) will terminate on December 7, 2023. A copy of your Separation and Release Agreement is enclosed with this letter.